Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies selective for cells presenting EGFR at high density

Antibodies selective for cells presenting EGFR at high density

US Patent 12084510 · Granted Sep 10, 2024

Estimated economic value: $216,607,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered TGF-beta monomers and their use for inhibiting TGF-beta signaling2025
Activin receptor type IIB variants and uses thereof2025
Anti-G-CSF antibodies and uses thereof2025
Anti-G-CSF antibodies and uses thereof2025
TGF-β-receptor ectodomain fusion molecules and uses thereof2025
TGF-β-receptor ectodomain fusion molecules and uses thereof2025
Antibody variants with pH-dependent antigen binding for selective targeting of s2025
Antibody variants with pH-dependent antigen binding for selective targeting of s2025
Antibody variants with pH-dependent antigen binding for selective targeting of s2025
Activin receptor type IIB variants and uses thereof2024
Antibodies and antibody fragments against HNAV1.7 channel and their use in pain 2024
TGF-β-receptor ectodomain fusion molecules and uses thereof2024